OSCR
Oscar Health, Inc.
OSCR has the edge over SMTI overall, supported by stronger fundamentals and stronger modeled upside.
SMTI
Sanara MedTech Inc.
SMTI has lower modeled downside risk, despite its lower overall score.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
SMTI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Under pressure |
SMTI's cash flow is currently healthy, and its revenue and profitability are stable, but its balance sheet is under pressure.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
SMTI PE Valuation
SMTI has no meaningful PE right now: it lost money over the past year.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
SMTI Forward outlook
There aren't enough analyst estimates for SMTI to show an outlook.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over SMTI on earnings quality, reporting a profit while its opponent remains loss making.
SMTI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.48 | +$3.74 |
| Q2 2026 | -$3.72 | -$2.56 |
| Q1 2026 | -$3.90 | -$2.56 |
| Q4 2025 | -$4.36 | -$3.22 |
| Q3 2025 | -$4.22 | -$3.23 |
| Q2 2025 | -$1.16 | -$0.38 |
| Q1 2025 | -$1.34 | -$0.75 |
| Q4 2024 | -$1.14 | -$0.62 |
SMTI lost $0.48 per share over the past year, a smaller loss than the year before.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over SMTI on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over SMTI on profitability, with a higher operating margin.
SMTI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28.4M | +8% |
| Q2 2026 | $28.1M | +8.9% |
| Q1 2026 | $27.8M | +19% |
| Q4 2025 | $27.5M | +4.7% |
| Q3 2025 | $26.3M | +22% |
| Q2 2025 | $25.8M | +28% |
| Q1 2025 | $23.4M | +26% |
| Q4 2024 | $26.3M | +49% |
SMTI's revenue has grown year over year every quarter since late 2020: $28M last quarter, up 8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -8.6 points |
| Q2 2026 | 6.3% | +6.5 points |
| Q1 2026 | 9.5% | +18 points |
| Q4 2025 | 3.8% | +5.2 points |
| Q3 2025 | 11% | +20 points |
| Q2 2025 | -0.1% | +14 points |
| Q1 2025 | -8.9% | -0.6 points |
| Q4 2024 | -1.4% | -0.1 points |
SMTI's operating margin was 2.6% last quarter, down 8.6 points from the same quarter a year ago.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR usually generates cash, though not every quarter: the latest was −$1.2B, but it generated $4.1B over the past year.
SMTI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.9M | +250% |
| Q2 2026 | $2M | +125% |
| Q1 2026 | -$2.5M | +$1.2M |
| Q4 2025 | $3.9M | +349% |
| Q3 2025 | $1.1M | -45% |
| Q2 2025 | $902.7K | +$2.4M |
| Q1 2025 | -$3.7M | -$2.1M |
| Q4 2024 | $859.9K | +$1.8M |
SMTI's free cash flow has turned positive again: $7M over the past year, against −$842,048 the year before.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
SMTI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.4% | +120K shares |
| 1 year | -1.8% | -158K shares |
| 3 years | +5.4% | +451K shares |
| 5 years | +17% | +1.3M shares |
| Available history | +41% | +2.6M shares |
SMTI has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q4 2019 | — |
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has the edge over SMTI on leverage, with a lower net debt burden relative to earnings.
SMTI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.4x | Elevated |
| Q2 2026 | 2.9x | Moderate |
| Q1 2026 | 3.4x | Elevated |
| Q4 2025 | 5.4x | High |
| Q3 2025 | 6.1x | High |
| Q2 2025 | 50.4x | High |
SMTI's net debt is about 3.4 years of its operating earnings (EBITDA), down from 6.1 years a year ago.
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
SMTI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.2 | Neutral |
| Stochastic | 55.3 | Neutral |
SMTI's weekly RSI is 59 (neutral) and its Stochastic is 55 (neutral).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
SMTI PE vs Healthcare Sector
SMTI has no meaningful PE right now: it lost money over the past year.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over SMTI on trend strength, trading above more of its moving averages.
SMTI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $33.5 | 2.8% below |
| 20 week MA | $32.2 | 1.2% above |
| 50 week MA | $25.5 | 28% above |
| 100 week MA | $28.0 | 16% above |
| 200 week MA | $32.0 | 1.8% above |
SMTI has slipped below its 8-week average, but it's still above the other four, and 1.8% above its 200-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over SMTI on returns for 2026, with the stronger performance.
SMTI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.0 | $51.7 | +223% |
| 2021 | $51.7 | $25.7 | -50% |
| 2022 | $25.7 | $42.8 | +66% |
| 2023 | $42.8 | $41.1 | -4% |
| 2024 | $41.1 | $33.5 | -18% |
| 2025 | $33.5 | $24.2 | -28% |
| 2026 YTD | $24.2 | $32.5 | +34% |
SMTI has finished three years in a row lower, and it's up 34% so far in 2026.